Gisens Biotech
PrivateLast Round
Accelerator
Aug 29, 2024
Est. Valuation
$2.61M
Total Funding Raised
$735,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Gisens Biotech operates in Healthcare & Life Sciences and is based in Berkeley, California. Its latest recorded funding round was an Accelerator round in August 2024.
Gisens Biotech is a biotechnology company that develops a graphene-based point-of-care diagnostic platform for real-time health monitoring.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Sensors
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gisens Biotech Comparables
Compare Gisens Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| StataDx, Inc. | 85% | |
| Aksense | 81% | |
| GrapheneDx | 80% |
For institutional investors. Book with your work email.
Gisens Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Aug 29, 2024 | ||||
| Accelerator | Aug 28, 2024 | ||||
| Accelerator | May 16, 2023 | ||||
| Seed | Mar 1, 2023 | ||||
| Grant | Mar 2, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Gisens Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FedTech | Accelerator |
| Activation Capital | Accelerator |
| gener8tor | Accelerator |
| Techstars | Accelerator |
| GRIDX | Seed |
| Seven Seven Six | Seed |
| R42 Group | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 49% MoM.
- Jan 1, 2026
Monthly visitors grew 92% MoM.
For institutional investors. Book with your work email.
Gisens Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Gisens Biotech's valuation, stock price, and market status.
Is Gisens Biotech a public or private company?
Gisens Biotech is a private company.
What is the current stock price of Gisens Biotech?
Gisens Biotech is a private company, so its shares have no public market price. Caplight tracks Gisens Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gisens Biotech worth (valuation)?
Gisens Biotech's valuation is estimated at $2.6M based on funding round data.
Can I buy Gisens Biotech stock?
Gisens Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gisens Biotech's last funding round?
Gisens Biotech's most recent funding round was Accelerator on August 29, 2024.
Who are the main investors in Gisens Biotech?
Key investors in Gisens Biotech include FedTech, Activation Capital, gener8tor, Techstars, GRIDX.
Will Gisens Biotech IPO soon?
No public IPO plans have been announced for Gisens Biotech.
How can I track Gisens Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Gisens Biotech's shares on secondary markets.